|Disease Group:||Blood And Marrow Transplantation; Pediatrics; Solid Tumors|
|Phase of Study:||Phase II|
Natural Killer Cells
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||Patients will be in the hospital at least one night following NK cell infusion |
and first dose of IL-2.
|Return Visit:||Once discharged, patients will return to MDACC at least two times per week |
until neutrophil recovery; then once a month for three months; then once every
three months until one year post infusion.
|Home Care:||Subcutaneous IL-2 three times a week for nine doses.|